Orthofix Medical Inc. (OFIX)
NASDAQ: OFIX · Real-Time Price · USD
10.80
+0.46 (4.40%)
Jun 23, 2025, 4:00 PM - Market closed
Orthofix Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 804.53 | 799.49 | 746.64 | 460.71 | 464.48 | 406.56 | Upgrade
|
| Revenue Growth (YoY) | 5.85% | 7.08% | 62.06% | -0.81% | 14.25% | -11.61% | Upgrade
|
| Cost of Revenue | 252.08 | 241.42 | 224.32 | 123.54 | 114.91 | 101.89 | Upgrade
|
| Gross Profit | 552.45 | 558.07 | 522.32 | 337.17 | 349.57 | 304.67 | Upgrade
|
| Selling, General & Admin | 533.82 | 532.53 | 530.4 | 308.78 | 290.67 | 272.38 | Upgrade
|
| Research & Development | 73.92 | 73.64 | 80.23 | 49.07 | 49.62 | 39.06 | Upgrade
|
| Operating Expenses | 621.64 | 623.6 | 628.08 | 367.64 | 349.7 | 318.24 | Upgrade
|
| Operating Income | -69.19 | -65.53 | -105.77 | -30.47 | -0.13 | -13.57 | Upgrade
|
| Interest Expense | -29.58 | -29.63 | -8.63 | -1.29 | -1.84 | -2.48 | Upgrade
|
| Currency Exchange Gain (Loss) | -4.55 | -5.02 | 2.59 | -3.29 | -3.98 | - | Upgrade
|
| Other Non Operating Income (Expenses) | 3.23 | 1.18 | -2 | 0.32 | 0.33 | 8.38 | Upgrade
|
| EBT Excluding Unusual Items | -100.1 | -99.01 | -113.81 | -34.72 | -5.62 | -7.67 | Upgrade
|
| Merger & Restructuring Charges | -12.19 | -12.19 | -36.04 | - | - | - | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -11.76 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -5.78 | -5.78 | -1.52 | -0.18 | 0.31 | - | Upgrade
|
| Other Unusual Items | -8.68 | -6.9 | 2.7 | 17.2 | 3.58 | 7.3 | Upgrade
|
| Pretax Income | -140.84 | -123.88 | -148.68 | -17.71 | -13.5 | -0.37 | Upgrade
|
| Income Tax Expense | 2.23 | 2.12 | 2.72 | 2.04 | 24.88 | -2.89 | Upgrade
|
| Earnings From Continuing Operations | -143.07 | -126 | -151.4 | -19.75 | -38.38 | 2.52 | Upgrade
|
| Net Income | -143.07 | -126 | -151.4 | -19.75 | -38.38 | 2.52 | Upgrade
|
| Net Income to Common | -143.07 | -126 | -151.4 | -19.75 | -38.38 | 2.52 | Upgrade
|
| Shares Outstanding (Basic) | 38 | 38 | 37 | 20 | 20 | 19 | Upgrade
|
| Shares Outstanding (Diluted) | 38 | 38 | 37 | 20 | 20 | 19 | Upgrade
|
| Shares Change (YoY) | 3.40% | 3.82% | 83.16% | 1.84% | 1.54% | 2.58% | Upgrade
|
| EPS (Basic) | -3.72 | -3.30 | -4.12 | -0.98 | -1.95 | 0.13 | Upgrade
|
| EPS (Diluted) | -3.72 | -3.30 | -4.12 | -0.98 | -1.95 | 0.13 | Upgrade
|
| Free Cash Flow | -4.8 | -9.09 | -107.8 | -34.7 | 0.69 | 51.55 | Upgrade
|
| Free Cash Flow Per Share | -0.13 | -0.24 | -2.94 | -1.73 | 0.04 | 2.66 | Upgrade
|
| Gross Margin | 68.67% | 69.80% | 69.96% | 73.18% | 75.26% | 74.94% | Upgrade
|
| Operating Margin | -8.60% | -8.20% | -14.17% | -6.61% | -0.03% | -3.34% | Upgrade
|
| Profit Margin | -17.78% | -15.76% | -20.28% | -4.29% | -8.26% | 0.62% | Upgrade
|
| Free Cash Flow Margin | -0.60% | -1.14% | -14.44% | -7.53% | 0.15% | 12.68% | Upgrade
|
| EBITDA | 26.11 | 10.43 | -45.21 | 1.61 | 32.96 | 20.71 | Upgrade
|
| EBITDA Margin | 3.25% | 1.31% | -6.05% | 0.35% | 7.10% | 5.09% | Upgrade
|
| D&A For EBITDA | 95.3 | 75.96 | 60.56 | 32.08 | 33.1 | 34.28 | Upgrade
|
| EBIT | -69.19 | -65.53 | -105.77 | -30.47 | -0.13 | -13.57 | Upgrade
|
| EBIT Margin | -8.60% | -8.20% | -14.16% | -6.61% | -0.03% | -3.34% | Upgrade
|
| Advertising Expenses | - | - | - | - | 0.5 | 0.9 | Upgrade
|
Updated May 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.